ValeurQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMFrais de vente, généraux et administratifs251.25 M247.78 M259.79 M265.09 M275.68 M294.37 M1.09 BRecherche et développement57.73 M59.06 M61.9 M63.41 M66.83 M65.79 M257.93 MRésultat d'exploitation261.69 M316.53 M373.05 M354.85 M315.61 M362.59 M1.41 BTotal des produits hors exploitation———————Charges d'intérêts, nettes des intérêts capitalisés7.5 M7.67 M11.32 M10.65 M9.21 M7.74 M38.93 MRésultat hors exploitation, hors charges d'intérêts———————Revenus/dépenses exceptionnels———————Résultat avant impôts256.39 M310.08 M362.35 M344.77 M306.98 M355.44 M1.37 BPart des actionnaires dans le résultat———————Impôts40.24 M67.41 M68.36 M70.16 M58.79 M77 M274.31 MIntérêts ne donnant pas le contrôle / intérêts minoritaires———————Autres produits/charges après impôts———————Résultat net avant activités abandonnées216.15 M242.68 M293.99 M274.61 M248.19 M278.45 M1.1 BActivités abandonnées———————Résultat net216.15 M242.68 M293.99 M274.61 M248.19 M278.45 M1.1 BAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires216.15 M242.68 M293.99 M274.61 M248.19 M278.45 M1.1 BBénéfice par action de base (BPA de base)2.642.983.663.433.13.513.69Bénéfice par action dilué (BPA dilué)2.622.963.633.43.093.4713.59Nombre moyen d'actions de base en circulation82.47 M81.32 M80.41 M80.1 M80.43 M79.65 M—Nombre d'actions en circulation après dilution83.25 M81.92 M80.99 M80.67 M81.03 M80.16 M—EBITDA291.82 M347.71 M405.88 M388.24 M349.43 M392.38 M1.54 BEBIT258.11 M313.64 M370.11 M351.61 M310.7 M354.7 M1.39 BCoût des ventes385.42 M375.05 M416.19 M423.5 M434.92 M422.02 M1.7 BAutres coûts des ventes———————Amortissements (flux de trésorerie)33.71 M34.06 M35.77 M36.63 M38.72 M37.68 M148.8 M
IDEXX Laboratories, Inc. - Common Stock
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.